ArticleBMC medical informatics and decision making2026
Predicting cognitive frailty in older adults: an explainable machine learning model integrating radiomics and clinical features.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDespite emerging research on clinical predictors of cognitive frailty (CF), no studies have yet leveraged radiomic methods to characterize this high-risk geriatric syndrome, creating a critical gap in neurostructural biomarker integration for early detection. This study aims to develop and validate machine learning models for predicting cognitive frailty in the elderly using MRI radiomics and clinical risk factors.
methodsThis retrospective study analyzed 173 patients undergoing brain MRI at our institution (April 2016–December 2021), categorized into cognitive frailty (CF, n = 83) and cognitively normal (CN, n = 90) groups based on IANA/IAGG criteria. Participants were randomly divided into training (n = 121) and test sets (n = 52; 7:3 ratio). Independent clinical predictors were identified through univariate analysis and binary logistic regression. Temporal lobe regions of interest (ROIs) were manually segmented on T2-FLAIR sequences, from which 1,130 radiomics features were extracted. Six machine learning models—logistic regression (LR), support vector machine (SVM), random forest (RF), k-nearest neighbors (KNN), gradient boosting decision tree (GBDT), and extreme gradient boosting (XGBoost)—were developed using two input modalities: (1) optimal radiomics features selected via t-tests and LASSO regression, and (2) combined radiomics-clinical features. Models were trained with 10-fold cross-validation and evaluated using ROC curves, AUC, accuracy, sensitivity, specificity, F1-score, Brier score, DeLong test (AUC comparison), and decision curve analysis (DCA). Model interpretability was quantified via SHAP (Shapley Additive Explanation) values.
resultsThe machine learning models integrating radiomics and clinical features demonstrated superior predictive performance for cognitive frailty (CF). Among the six algorithms evaluated, the SVM model achieved superior predictive accuracy with an accuracy of 0.865, specificity of 0.963, sensitivity of 0.760, F1 score of 0.844, AUC-ROC of 0.914 (95% CI = 0.818–0.990) on the testing set. Integrated radiomics-clinical models significantly outperformed radiomics-only models (DeLong test: P < 0.05; DCA showing superior net benefit). SHAP analysis identified grip strength, age, and four radiomics features (wavelet-HLL_glcm_Imc1, exponential_glcm_Idmn, original_shape_MajorAxisLength, gradient_firstorder_Skewness) as top predictors.
conclusionMachine learning models integrating MRI radiomics and clinical features effectively predict cognitive frailty, with SVM demonstrating the highest diagnostic accuracy. This interpretable multimodal approach offers a promising decision-support tool for early CF detection in elderly populations. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.